REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Usfa Vet Farma (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pt Usfa Vet Farma Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Usfa Vet Farma is an enterprise based in Indonesia. Its main office is in Mojokerto. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 30, 1985. From the latest financial highlights, Pt Usfa Vet Farma reported a net sales revenue increase of 12.69% in 2024. There was a total growth of 14.21% in Pt Usfa Vet Farma’s total assets over the same period.

Headquarters
KM 49
Mojokerto; East Java; Postal Code: 61383

Contact Details: Purchase the Pt Usfa Vet Farma report to view the information.

Website: http://www.ptusfavetfarma.co.id

Basic Information
Registered Capital:
Purchase the Pt Usfa Vet Farma report to view the information.
Financial Auditors:
Purchase the Pt Usfa Vet Farma report to view the information.
Incorporation Date:
May 30, 1985
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Usfa Vet Farma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
12.69%
Total Operating Revenue
12.69%
Total Assets
14.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?